2025-01-17 13:52:41
Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC
Health/ 2023-07-22
Himalaya Therapeutics Announces Submissi...

SHANGHAI and SAN DIEGO,Oct. 5,2021--Himalaya Therapeutics("Himalaya"),a clinical-stage biopharmaceutical company focused ondevelop...

RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients
Corporate/ 2023-07-23
RedHill Biopharma Reports Further Analys...

TEL AVIV,Israel and RALEIGH,N.C.,Oct. 4,2021-- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"),a spec...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release